Mercedes Garayoa

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Multiple Myeloma

Induced Apoptosis

Newly Diagnosed

Histone Deacetylase

Top Venues

International journal of molecular sciences

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Díaz-Tejedor, Javier Rodríguez-Ubreva, Laura Ciudad, Mauro Lorenzo-Mohamed, Marta González-Rodríguez, Bárbara Castellanos, Janet Sotolongo-Ravelo, Laura San-Segundo, Luis-Antonio Corchete, Lorena González-Méndez, Montserrat Martín-Sánchez, Maria-Victoria Mateos-Manteca, Enrique María Ocio, Mercedes Garayoa, Teresa Paíno
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. International journal of molecular sciences 25 (9) (2024)
Andrea Díaz-Tejedor, Javier Rodríguez-Ubreva, Laura Ciudad, Mauro Lorenzo-Mohamed, Marta González-Rodríguez, Bárbara Castellanos, Janet Sotolongo-Ravelo, Laura San-Segundo, Luis-Antonio Corchete, Lorena González-Méndez, Montserrat Martín-Sánchez, Maria-Victoria Mateos-Manteca, Enrique María Ocio, Mercedes Garayoa, Teresa Paíno
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. International journal of molecular sciences 25 (9) (2024)
Andrea Díaz-Tejedor, Javier Rodríguez-Ubreva, Laura Ciudad, Mauro Lorenzo-Mohamed, Marta González-Rodríguez, Bárbara Castellanos, Janet Sotolongo-Ravelo, Laura San-Segundo, Luis-Antonio Corchete, Lorena González-Méndez, Montserrat Martín-Sánchez, Maria-Victoria Mateos-Manteca, Enrique María Ocio, Mercedes Garayoa, Teresa Paíno
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands. International journal of molecular sciences 25 (9) (2024)
Esperanza M Algarín, Dalia Quwaider, Francisco J Campos-Laborie, Andrea Díaz-Tejedor, Pedro Mogollón, Elena Vuelta, Montserrat Martín-Sánchez, Laura San-Segundo, Lorena González-Méndez, Norma C Gutiérrez, Miriam Santero, Teresa Paíno, Javier De Las Rivas, Enrique María Ocio, Mercedes Garayoa
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma. Cells 10 (3) (2021)
Patricia Maiso, Pedro Mogollón, Enrique María Ocio, Mercedes Garayoa
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression. Cancers 13 (11) (2021)
Antonio Garcia-Gomez, Tianlu Li, Carlos de la Calle-Fabregat, Javier Rodríguez-Ubreva, Laura Ciudad, Francesc Català-Moll, Gerard Godoy-Tena, Montserrat Martín-Sánchez, Laura San-Segundo, Sandra Muntión, Xabier Morales, Carlos Ortiz de Solórzano, Julen Oyarzabal, Edurne San José-Enériz, Manel Esteller, Xabier Agirre, Felipe Prosper, Mercedes Garayoa, Esteban Ballestar
Targeting aberrant DNA methylation in mesenchymal stromal cells as a treatment for myeloma bone disease. Nature communications 12 (1) (2021)
Andrea Díaz-Tejedor, Mauro Lorenzo-Mohamed, Noemí Puig, Miriam Santero, Maria-Victoria Mateos-Manteca, Mercedes Garayoa, Teresa Paíno
Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression. Cancers 13 (6) (2021)
Teresa Paíno, Lorena González-Méndez, Laura San-Segundo, Luis-Antonio Corchete, Susana Hernández-García, Andrea Díaz-Tejedor, Esperanza M Algarín, Pedro Mogollón, Montserrat Martín-Sánchez, Norma C Gutiérrez, María-Victoria Mateos, Mercedes Garayoa, Enrique María Ocio
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma. Cancers 12 (10) (2020)
Elena González-Hernández, Rubén Aparicio, Mercedes Garayoa, M José Montero, M Ángeles Sevilla, Concepción Pérez-Melero
Dihydropyrimidine-2-thiones as Eg5 inhibitors and L-type calcium channel blockers: potential antitumour dual agents. MedChemComm 10 (9) (2019)
Pedro Mogollón, Andrea Díaz-Tejedor, Esperanza M Algarín, Teresa Paíno, Mercedes Garayoa, Enrique María Ocio
Biological Background of Resistance to Current Standards of Care in Multiple Myeloma. Cells 8 (11) (2019)